New rotavirus vaccine gets endorsed by ACIP

February 27, 2006

Merck's new vaccine against rotavirus infection, RotaTeq, has been added to the Advisory Committee on Immunization Practices (ACIP) list of routinely recommended childhood immunizations. Rotavirus usually manifests itself as gastroenteritis and affects about 2.7 million children under the age of five in the United States, resulting in an estimated 70,000 hospitalizations.

New rotavirus vaccine gets endorsed by ACIP

Merck's new vaccine against rotavirus infection, RotaTeq, has been added to the Advisory Committee on Immunization Practices (ACIP) list of routinely recommended childhood immunizations. Rotavirus usually manifests itself as gastroenteritis and affects about 2.7 million children under the age of five in the United States, resulting in an estimated 70,000 hospitalizations. The virus kills about 600,000 children annually in countries without adequate health care. ACIP recommends RotaTeq vaccine be delivered by mouth, in three doses, at two months, four months, and six months of age.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.